کد مقاله | کد نشریه | سال انتشار | مقاله انگلیسی | نسخه تمام متن |
---|---|---|---|---|
3380558 | 1220214 | 2010 | 4 صفحه PDF | دانلود رایگان |
SummaryObjectiveTo update a published meta-analysis of double-blind placebo-controlled randomized clinical trials (RCTs) to assess the efficacy of chondroitin sulfate as a structure-modifying drug for knee osteoarthritis (OA).DesignA published meta-analysis of randomized controlled trials was updated to include data from one new trial and final data from a second trial both published recently in peer-reviewed literature. This meta-analysis was limited to three RCTs of 2-year duration. Data were pooled using a fixed effects model as there was no evidence of important heterogeneity.ResultsPooled results demonstrated a small significant effect of chondroitin sulfate on the reduction in rate of decline in minimum joint space width of 0.13 mm [95% confidence interval (CI) 0.06, 0.19] (P = 0.0002) that corresponded to an effect size of 0.23 (95% CI 0.11, 0.35) (P = 0.0001).ConclusionThese results demonstrate that chondroitin sulfate is effective for reducing the rate of decline in minimum joint space width in patients with knee OA.
Journal: Osteoarthritis and Cartilage - Volume 18, Supplement 1, June 2010, Pages S28–S31